APYX News and Press, Apyx Medical Corporation From 05/26/22

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® and J-Plasma ® in surgical markets, today announced it has received 510(k) c...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical markets, announced today that management will participate i...

Apyx Medical Corporation (APYX) Q1 2022 Earnings Conference Call May 12, 2022 08:00 ET Company Participants Charles Goodwin - President & Chief Executive Officer Tara Semb - Chief Financial Officer, Treasurer & Secretary Conference Call Participants Matthew Hewitt - Craig-Hallum Capit...

Apyx Medical press release (NASDAQ:APYX): Q1 GAAP EPS of -$0.17. Revenue of $12.5M (+44.7% Y/Y). For further details see: Apyx Medical GAAP EPS of -$0.17, revenue of $12.5M

Advanced Energy sales increased 41% year-over-year in Q1 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma&...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apyx Medical Corp. (“Apyx” or the “Company”) (NASDAQ: APYX) on behalf of Apyx stockholders. Our investigation concerns whether Apyx...

Apyx Medical Corporation (NASDAQ:APYX) traded at a new 52-week high today of $19.60. So far today approximately 6.8 million shares have been exchanged, as compared to an average 30-day volume of 147,000 shares. There is potential upside of 5.4% for shares of Apyx Medical Corporation base...

Apyx Medical Corporation (NASDAQ:APYX) traded today at a new 52-week high of $19.60. Approximately 6.8 million shares have changed hands today, as compared to an average 30-day volume of 143,000 shares. Over the past year, Apyx Medical Corporation has traded in a range of $2.81 to $17.50...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Apyx Medical (NASDAQ:APYX) submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for expanding the use of Renuvion APR Handpiece to improve the appearance of lax (loose) skin in the neck and submental region. The application is aimed at expanding Renuvion APR Hand...